We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Vital Signs Monitor Incorporates SET Technology

By HospiMedica International staff writers
Posted on 03 Mar 2011
A new vital signs monitor offers a host of noninvasive, continuous, measurements and patient monitoring capabilities, including Masimo rainbow SET Pulse CO-Oximetry (SpO2) technology. More...


The Connex Vital Signs Monitor (CVSM) is a full-color, touch screen device that acts as three devices in one, providing comprehensive patient documentation on a single display, including automatic measurements of heart rate, blood pressure (BP), temperature, and pulse oximetry; manual parameters such as respiration, height, weight, and pain level; and modifiers such as body position, Oxygen (O2) therapy details, and others. The device also gives the clinician the ability to control alarms, patient data, and monitoring, in a customized manner for each patient, and document the data right on the device, eliminating the need to locate a PC and transcribe it later.

The CVSM monitor also integrates Masimo (Irvine, CA, USA) rainbow SETSpO2-enabled measurements, and is capable of being field upgraded to add other rainbow SET measurements as they become commercially available for use with the CVSM. These will eventually include Masimo rainbow SET noninvasive and continuous measurements such as total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet), Pleth Variability Index (PVI), and rainbow Acoustic Monitoring (RAM). The CVSM is a product of Welch Allyn (Skaneateles Falls, NY, USA).

"Welch Allyn is excited to provide our customers with the option of enabling the Masimo parameters within our patient monitoring devices in a manner that considers their evolving needs over time,” said Steve Meyer, executive vice president and chief global business officer at Welch Allyn. "Masimo technology supports our platform concept of modularity and upgradeability while allowing customers to improve patient care through early, noninvasive continuous and spot check monitoring of key hemodynamic parameters.”

Conventional pulse oximetry assumes that arterial blood is the only blood pulsating in the measurement site. During patient motion, the venous blood also moves, which causes conventional pulse oximetry to under-read because it cannot distinguish between the arterial and venous blood. Masimo SET signal processing identifies the venous blood signal, isolates it, and uses adaptive filters to cancel the noise and extract the arterial signal in order to report the true arterial oxygen saturation and pulse rate.

Related Links:

Masimo
Welch Allyn



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.